Evidence map›Paper›PMID 42840250›Full record

ArticleAIDS research and treatment2026

Effect of Antiretroviral Therapy, Immune Dysregulation, and COVID-19 Vaccination on SARS-CoV-2 Outcomes in PLWHA in Kenya.

James Kinoti Njue, Lihana Wekesa, Alex Maiyo, Zakayo Maingi Mwangi, Dorothy Kagendo, Raphael Mwamtsi Lwembe

Abstract read
In one paragraph

Article in AIDS research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James Kinoti NjueSchool of Medicine Moi University Eldoret Kenya mu.ac.ke.ORCID https://orcid.org/0000-0003-1462-2057
Lihana WekesaCentre for Virus Research (CVR) Kenya Medical Research Institute (KEMRI) Nairobi Kenya kemri.org.
Alex MaiyoCentre for Virus Research (CVR) Kenya Medical Research Institute (KEMRI) Nairobi Kenya kemri.org.
Zakayo Maingi MwangiDepartment of Medical Laboratory Science Meru University of Technology Meru Kenya.
Dorothy KagendoSchool of Nursing and Public Health Chuka University Chuka Kenya chuka.ac.ke.
Raphael Mwamtsi LwembeCentre for Virus Research (CVR) Kenya Medical Research Institute (KEMRI) Nairobi Kenya kemri.org.ORCID https://orcid.org/0000-0001-5877-1367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People living with HIV (PLWHA) may experience increased vulnerability to SARS-CoV-2 infection and severe COVID-19 due to immune dysregulation, comorbidities, and treatment adherence challenges. Kenya has over 1.4 million PLWHA. However, only a few have been reported with severe COVID-19, suggesting potential protective roles of antiretroviral therapy (ART), management of comorbidities, and COVID-19 vaccination. Methods: This study was conducted across high HIV-prevalence regions in Kenya (Nakuru, Malindi/Mariakani, and Kisumu). A cross-sectional survey evaluates clinical characteristics and self-reported COVID-19 vaccination outcomes among 303 PLWHA. Quantitative data were collected through structured questionnaires and clinical records. Associations between ART, immune markers (CD4/CD8 counts; viral load), COVID-19 vaccination, and SARS-CoV-2 infection and severity were tested using Chi-square and Fisher's exact tests. Results: An analysis of 303 participants (70.6% female, median age 40) revealed an 86.5% COVID-19 vaccination rate and 94.1% ART adherence. Only 9.2% reported prior SARS-CoV-2 infection, mostly mild, potentially indicating underreporting or asymptomatic cases. Interestingly, missing ART doses were significantly associated with contracting SARS-CoV-2 ( Conclusion: Low COVID-19 rates were observed. All cases occurred in vaccinated participants, likely reflecting health-seeking bias rather than vaccine failure. Missing ART doses were significantly associated with infection. Optimal risk mitigation requires integrated strategies prioritizing both high vaccine coverage and strict ART adherence.

Indexed as

ARTCOVID-19HIVimmune dysregulationKenyaSARS-CoV-2vaccination

Identifiers

PMID42840250
PMCPMC13639233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.